We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock
GHSI

Delisted

GHSI was delisted on the 11th of October, 2024.

Back to rankings

22 hedge funds and large institutions have $546K invested in Guardion Health Sciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 23 → 22 (-1)

17% less capital invested

Capital invested by funds: $659K → $546K (-$113K)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$7.5K
2
Jane Street
Jane Street
New York
+$4.45K
3
HF
HRT Financial
New York
+$3.52K
4
Morgan Stanley
Morgan Stanley
New York
+$2.27K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.02K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$99.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$28.1K
3
E
Ergoteles
New York
-$19K
4
VF
Virtu Financial
New York
-$11K
5
Renaissance Technologies
Renaissance Technologies
New York
-$8.52K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG
26
StoneX Group
New York
– -$1.89K -274 Closed
1
2

GHSI Hedge Fund Activity: Q4 2022 in Review

22 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2022, worth a combined $546K — down 17% from $659K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of GHSI and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $7.5K. The largest seller was Millennium Management, cutting an estimated $99.4K.

  • 22 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2022, down from 23 in Q3 2022.
  • Funds reported $546K of Guardion Health Sciences, Inc. Common Stock stock for Q4 2022, down 17% quarter-over-quarter.
  • 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2022 and 5 closed out, a net change of -1 holder.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2022 was Citadel Advisors, an estimated $7.5K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2022 was Millennium Management, an estimated $99.4K sold.

Based on aggregated 13F filings for Q4 2022.